Estimating glomerular filtration rate in acute coronary syndromes: Different equations, different mortality risk

Inês Almeida1, Francisca Caetano2, Sérgio Barra3

  • 1Cardiology Department, Coimbra University Hospital Centre, Portugal inesalm@gmail.com.

Insights

The CKD-EPIcyst equation, using cystatin C, best predicts mid-term mortality in acute coronary syndrome patients. It outperforms the MDRD-4 formula and enhances the GRACE score for improved risk assessment.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Epidemiology

Background:

  • Renal dysfunction is a key predictor of adverse outcomes in acute coronary syndrome (ACS) patients.
  • New estimated glomerular filtration rate (eGFR) equations (CKD-EPIcreat, CKD-EPIcyst, CKD-EPIcreat/cyst) are recommended for assessing renal function.
  • The predictive value of these new equations for mortality in ACS patients requires thorough investigation.

Purpose of the Study:

  • To evaluate the mid-term mortality predictive value of three new eGFR estimating equations.
  • To compare the performance of CKD-EPIcreat, CKD-EPIcyst, and CKD-EPIcreat/cyst with the traditional MDRD-4 formula.
  • To assess the added prognostic power of these equations to existing risk scores.

Main Methods:

  • 801 patients hospitalized for ACS were included and followed for approximately 24 months.
  • Patients were stratified into high-risk (eGFR<60ml/min/1.73m²) and low-risk (eGFR≥60ml/min/1.73m²) groups based on each eGFR equation.
  • Predictive performance was compared using receiver operating characteristic curves (AUCs) and net reclassification improvement (NRI).

Main Results:

  • The CKD-EPIcyst equation demonstrated the highest discrimination for mid-term mortality (AUC 0.782±0.20), outperforming all other equations.
  • CKD-EPIcyst significantly improved risk reclassification compared to the MDRD-4 formula (NRI 11.9%, p=0.003).
  • The CKD-EPIcyst equation significantly enhanced the predictive capability of the GRACE score for mid-term mortality.

Conclusions:

  • The CKD-EPIcyst equation offers a superior method for assessing mid-term mortality risk in ACS patients.
  • Cystatin C-based eGFR estimation provides significant added value for risk stratification in this population.
  • These findings support the routine use of CKD-EPIcyst for improved patient management and risk prediction in ACS.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
323
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
123
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
359
Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
3.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
564